Browsing by Author Spelman, Timothy

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 19 of 19
Issue DateTitleAuthor(s)Citation
2013The Australian Multiple Sclerosis (MS) immunotherapy study: a prospective, multicentre study of drug utilisation using the MSBase platformBarnett, Michael; Vucic, Steve; Butzkueven, Helmut; Jokubaitis, Vilija; Lechner-Scott, Jeanette; Liew, D; Shaw, C; Slee, Mark; Spelman, Timothy; Central Clinical School: Inst. of Clinical Neurosciences; Western Clinical School: Medicine (Westmead)The Australian Multiple Sclerosis (MS) immunotherapy study: a prospective, multicentre study of drug utilisation using the MSBase platform, PLoS One, vol.8, 3, 2013,pp 1-9
2015Comparative efficacy of switching to natalizumab in active multiple sclerosisBarnett, Michael; Belachew, Shibeshih; et al, Various; Hyde, Robert; Kalincik, Tomas; Kappos, L.; Pellegrini, Fabio; Spelman, Timothy; Tsvetkova, Larisa; Wiendl, Heinz; Zhang, Annie; Central Clinical School: Inst. of Clinical NeurosciencesComparative efficacy of switching to natalizumab in active multiple sclerosis, Annals of Clinical and Translational Neurology, vol.2, 4, 2015,pp 373-387
2012Country, Sex, EDSS Change and Therapy Choice Independently Predict Treatment Discontinuation in Multiple Sclerosis and Clinically Isolated Syndrome.Barnett, Michael; Boz, C; et al, Various; Girard, M; Grand'Maison, Francois; Izquierdo, G; Jokubaitis, V; Lugaresi, Alessandro; Meyniel, Claire; Oreja-Guevara, C; Spelman, Timothy; Trojano, Maria; Central Clinical School: Inst. of Clinical NeurosciencesCountry, Sex, EDSS Change and Therapy Choice Independently Predict Treatment Discontinuation in Multiple Sclerosis and Clinically Isolated Syndrome., PLoS One, vol.7, 6, 2012,pp 1-8
2016Discontinuing disease-modifying therapy in MS after a prolonged relapse-free period: A propensity score-matched studyBarnett, Michael; Alroughani, Raed; Duquette, P; et al, Various; Grammond, Pierre; Grand' Maison, Francois; Kister, Ilya; Lechner-Scott, Jeannette; Lugaresi, Alessandra; Slee, Mark; Spelman, Timothy; Central Clinical School: Inst. of Clinical NeurosciencesDiscontinuing disease-modifying therapy in MS after a prolonged relapse-free period: A propensity score-matched study, Journal of Neurology, Neurosurgery and Psychiatry, vol.87, 10, 2016,pp 1133-1137
2016Discontinuing disease-modifying therapy in MS after a prolonged relapse-free period: A propensity score-matched studyBarnett, Michael; Alroughani, Raed; Duquette, P; et al, Various; Grammond, Pierre; Grand' Maison, Francois; Kister, Ilya; Lechner-Scott, Jeannette; Lugaresi, Alessandra; Slee, Mark; Spelman, Timothy; Central Clinical School: Inst. of Clinical NeurosciencesDiscontinuing disease-modifying therapy in MS after a prolonged relapse-free period: A propensity score-matched study, Journal of Neurology, Neurosurgery and Psychiatry, vol.87, 10, 2016,pp 1133-1137
2016The effect of oral immunomodulatory therapy on treatment uptake and persistence in multiple sclerosisBarnett, Michael; Boz, Cavit; et al, Various; Grand'Maison, Francois; Havrdova, Eva; Horakova, Dana; Izquierdo, Guillermo; Lugaresi, Alessandra; Spelman, Timothy; Trojano, Maria; Warrender-Sparkes, Matthew; Central Clinical School: Inst. of Clinical NeurosciencesThe effect of oral immunomodulatory therapy on treatment uptake and persistence in multiple sclerosis, Multiple Sclerosis Journal, vol.22, 4, 2016,pp 520-532
2012The Kurtzke EDSS rank stability increases 4 years after the onset of multiple sclerosis: results from the MSBase RegistryBarnett, Michael; Duquette, P; et al, Various; Girard, Marc; Grammond, P; Grand'Maison, Francois; Hughes, Stella; Izquierdo, G; Lugaresi, Alessandra; Oreja-Guevara, C; Spelman, Timothy; Trojano, Maria; Central Clinical School: Inst. of Clinical NeurosciencesThe Kurtzke EDSS rank stability increases 4 years after the onset of multiple sclerosis: results from the MSBase Registry, Journal of Neurology, Neurosurgery and Psychiatry, vol.83, 3, 2012,pp 305-310
2013Persistence on Therapy and Propensity Matched Outcome Comparison of Two Subcutaneous Interferon Beta 1a Dosages for Multiple SclerosisBarnett, Michael; Vucic, Steve; Cristiano, E; Duquette, P; et al, Various; Grammond, P; Hupperts, R; Izquierdo, G; Kalinick, Tomas; Lugaresi, Alessandra; Spelman, Timothy; Trojano, Maria; Van Pesch, V; Central Clinical School: Inst. of Clinical Neurosciences; Western Clinical School: Medicine (Westmead)Persistence on Therapy and Propensity Matched Outcome Comparison of Two Subcutaneous Interferon Beta 1a Dosages for Multiple Sclerosis, PLoS One, vol.8, 5, 2013,pp 1-9
2014Predictors and dynamics of postpartum relapses in women with multiple sclerosisBarnett, Michael; Vucic, Steve; Boz, Cavit; Duquette, P; et al, Various; Girard, Marc; GrandMaison, Francois; Gray, Orla; Hughes, Stella; Izquierdo, Guillermo; Lugaresi, Alessandra; Spelman, Timothy; Trojano, Maria; Central Clinical School: Inst. of Clinical Neurosciences; Western Clinical School: Medicine (Westmead)Predictors and dynamics of postpartum relapses in women with multiple sclerosis, Multiple Sclerosis Journal, vol.20, 6, 2014,pp 739-746
2015Predictors of disability worsening in clinically isolated syndromeBarnett, Michael; Boz, Cavit; Cabrera-Gomez, Jose; Duquette, P; et al, Various; Girard, Marc; Giuliani, G; Grammond, P; Grand'Maison, Francois; Hupperts, R; Izquierdo, Guillermo; Jokubaitis, Vilija; Kalincik, Tomas; Lugaresi, Alessandra; Oreja-Guevara, C; Spelman, Timothy; Central Clinical School: Inst. of Clinical NeurosciencesPredictors of disability worsening in clinically isolated syndrome, Annals of Clinical and Translational Neurology, vol.2, 5, 2015,pp 479-491
2016Risk of early relapse following the switch from injectables to oral agents for multiple sclerosisBarnett, Michael; Vucic, Steve; Burke, Therese Valerie; Butzkueven, Helmut; Duquette, P; et al, Various; Grammond, Pierre; Grand' Maison, Francois; Havrdova, Eva; Hodgkinson, Suzanne J; Horakova, Dana; Izquierdo, Guillermo; Mekhael, L; Spelman, Timothy; Central Clinical School: Inst. of Clinical Neurosciences; Western Clinical School: Medicine (Westmead)Risk of early relapse following the switch from injectables to oral agents for multiple sclerosis, European Journal of Neurology, vol.23, 4, 2016,pp 729-776
2016Risk of early relapse following the switch from injectables to oral agents for multiple sclerosisBarnett, Michael; Vucic, Steve; Burke, Therese Valerie; Butzkueven, Helmut; Duquette, P; et al, Various; Grammond, Pierre; Grand' Maison, Francois; Havrdova, Eva; Hodgkinson, Suzanne J; Horakova, Dana; Izquierdo, Guillermo; Mekhael, L; Spelman, Timothy; Central Clinical School: Inst. of Clinical Neurosciences; Western Clinical School: Medicine (Westmead)Risk of early relapse following the switch from injectables to oral agents for multiple sclerosis, European Journal of Neurology, vol.23, 4, 2016,pp 729-776
2014Seasonal variation of relapse rate in multiple sclerosis is latitude dependentBarnett, Michael; Vucic, Steve; Bergamaschi, R; Boz, Cavit; Duquette, P; et al, Various; Giuliani, G; Grammond, P; Gray, Orla; Hupperts, R; Izquierdo, Guillermo; Lugaresi, Alessandra; Oreja-Guevara, C; Petersen, Thor; Spelman, Timothy; Trojano, Maria; Verheul, F; Central Clinical School: Inst. of Clinical Neurosciences; Western Clinical School: Medicine (Westmead)Seasonal variation of relapse rate in multiple sclerosis is latitude dependent, Annals of Neurology, vol.76, 6, 2014,pp 880-890
2014Seasonal variation of relapse rate in multiple sclerosis is latitude dependentBarnett, Michael; Vucic, Steve; Bergamaschi, R; Boz, Cavit; Duquette, P; et al, Various; Giuliani, G; Grammond, P; Gray, Orla; Hupperts, R; Izquierdo, Guillermo; Lugaresi, Alessandra; Oreja-Guevara, C; Petersen, Thor; Spelman, Timothy; Trojano, Maria; Verheul, F; Central Clinical School: Inst. of Clinical Neurosciences; Western Clinical School: Medicine (Westmead)Seasonal variation of relapse rate in multiple sclerosis is latitude dependent, Annals of Neurology, vol.76, 6, 2014,pp 880-890
2014Seasonal variation of relapse rate in multiple sclerosis is latitude dependentBarnett, Michael; Vucic, Steve; Bergamaschi, R; Boz, Cavit; Duquette, P; et al, Various; Giuliani, G; Grammond, P; Gray, Orla; Hupperts, R; Izquierdo, Guillermo; Lugaresi, Alessandra; Oreja-Guevara, C; Petersen, Thor; Spelman, Timothy; Trojano, Maria; Verheul, F; Central Clinical School: Inst. of Clinical Neurosciences; Western Clinical School: Medicine (Westmead)Seasonal variation of relapse rate in multiple sclerosis is latitude dependent, Annals of Neurology, vol.76, 6, 2014,pp 880-890
2014Seasonal variation of relapse rate in multiple sclerosis is latitude dependentBarnett, Michael; Vucic, Steve; Bergamaschi, R; Boz, Cavit; Duquette, P; et al, Various; Giuliani, G; Grammond, P; Gray, Orla; Hupperts, R; Izquierdo, Guillermo; Lugaresi, Alessandra; Oreja-Guevara, C; Petersen, Thor; Spelman, Timothy; Trojano, Maria; Verheul, F; Central Clinical School: Inst. of Clinical Neurosciences; Western Clinical School: Medicine (Westmead)Seasonal variation of relapse rate in multiple sclerosis is latitude dependent, Annals of Neurology, vol.76, 6, 2014,pp 880-890
2014Seasonal variation of relapse rate in multiple sclerosis is latitude dependentBarnett, Michael; Vucic, Steve; Bergamaschi, R; Boz, Cavit; Duquette, P; et al, Various; Giuliani, G; Grammond, P; Gray, Orla; Hupperts, R; Izquierdo, Guillermo; Lugaresi, Alessandra; Oreja-Guevara, C; Petersen, Thor; Spelman, Timothy; Trojano, Maria; Verheul, F; Central Clinical School: Inst. of Clinical Neurosciences; Western Clinical School: Medicine (Westmead)Seasonal variation of relapse rate in multiple sclerosis is latitude dependent, Annals of Neurology, vol.76, 6, 2014,pp 880-890
2015Switch to natalizumab versus fingolimod in active relapsing-remitting multiple sclerosisBarnett, Michael; Alroughani, Raed; Duquette, P; et al, Various; Girard, Marc; Grammond, P; Horakova, Dana; Izquierdo, Guillermo; Jokubaitis, Vilija; Kalincik, Tomas; Lechner-Scott, Jeannette; Lugaresi, Alessandra; Pucci, Eugenio; Rozsa, Csilla; Spelman, Timothy; Trojano, Maria; Central Clinical School: Inst. of Clinical NeurosciencesSwitch to natalizumab versus fingolimod in active relapsing-remitting multiple sclerosis, Annals of Neurology, vol.77, 3, 2015,pp 425-435
2017Towards personalized therapy for multiple sclerosis: Prediction of individual treatment responseBarnett, Michael; Vucic, Steve; et al, Various; Havrdova, Eva; Horakova, Dana; Izquierdo, Guillermo; Jokubaitis, Vilija; Kalincik, Tomas; Manouchehrinia, Ali; Sobisek, Lukas; Spelman, Timothy; Trojano, Maria; Central Clinical School: Inst. of Clinical Neurosciences; Westmead Clinical School: MedicineTowards personalized therapy for multiple sclerosis: Prediction of individual treatment response, Brain, vol.140, 9, 2017,pp 2426-2443